nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP1A2—chronic obstructive pulmonary disease	0.473	1	CbGaD
Anastrozole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0546	0.156	CbGbCtD
Anastrozole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0546	0.156	CbGbCtD
Anastrozole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0516	0.147	CbGbCtD
Anastrozole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0419	0.119	CbGbCtD
Anastrozole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0414	0.118	CbGbCtD
Anastrozole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0283	0.0807	CbGbCtD
Anastrozole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.027	0.077	CbGbCtD
Anastrozole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0241	0.0686	CbGbCtD
Anastrozole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0141	0.0402	CbGbCtD
Anastrozole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0133	0.038	CbGbCtD
Anastrozole—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00178	0.0587	CbGpPWpGaD
Anastrozole—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00155	0.0513	CbGpPWpGaD
Anastrozole—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00137	0.0453	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00125	0.0411	CbGpPWpGaD
Anastrozole—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00112	0.0371	CbGpPWpGaD
Anastrozole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.000778	0.0257	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.000722	0.0238	CbGpPWpGaD
Anastrozole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000708	0.0233	CbGpPWpGaD
Anastrozole—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000571	0.0188	CbGpPWpGaD
Anastrozole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000567	0.0187	CbGpPWpGaD
Anastrozole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000565	0.0186	CbGpPWpGaD
Anastrozole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000514	0.017	CbGpPWpGaD
Anastrozole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000483	0.0159	CbGpPWpGaD
Anastrozole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000439	0.0145	CbGpPWpGaD
Anastrozole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000437	0.0144	CbGpPWpGaD
Anastrozole—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000434	0.0143	CbGpPWpGaD
Anastrozole—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.0123	CbGpPWpGaD
Anastrozole—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000359	0.0119	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000359	0.0118	CbGpPWpGaD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000351	0.0116	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000346	0.0114	CbGpPWpGaD
Anastrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000339	0.0112	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.0108	CbGpPWpGaD
Anastrozole—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000315	0.0104	CbGpPWpGaD
Anastrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000295	0.00972	CbGpPWpGaD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00938	CbGpPWpGaD
Anastrozole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00915	CbGpPWpGaD
Anastrozole—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000272	0.00895	CbGpPWpGaD
Anastrozole—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00884	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000266	0.00878	CbGpPWpGaD
Anastrozole—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00181	CcSEcCtD
Anastrozole—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00181	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.0018	CcSEcCtD
Anastrozole—Cough—Formoterol—chronic obstructive pulmonary disease	0.000262	0.0018	CcSEcCtD
Anastrozole—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.0018	CcSEcCtD
Anastrozole—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000261	0.00861	CbGpPWpGaD
Anastrozole—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00179	CcSEcCtD
Anastrozole—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000259	0.00178	CcSEcCtD
Anastrozole—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000259	0.00178	CcSEcCtD
Anastrozole—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00178	CcSEcCtD
Anastrozole—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000257	0.00847	CbGpPWpGaD
Anastrozole—Cough—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00177	CcSEcCtD
Anastrozole—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00176	CcSEcCtD
Anastrozole—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000255	0.00175	CcSEcCtD
Anastrozole—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.00175	CcSEcCtD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000255	0.0084	CbGpPWpGaD
Anastrozole—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000255	0.00175	CcSEcCtD
Anastrozole—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000255	0.00175	CcSEcCtD
Anastrozole—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00175	CcSEcCtD
Anastrozole—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00174	CcSEcCtD
Anastrozole—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00174	CcSEcCtD
Anastrozole—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000252	0.00832	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000251	0.00829	CbGpPWpGaD
Anastrozole—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00172	CcSEcCtD
Anastrozole—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00172	CcSEcCtD
Anastrozole—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00172	CcSEcCtD
Anastrozole—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00172	CcSEcCtD
Anastrozole—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00025	0.00172	CcSEcCtD
Anastrozole—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00171	CcSEcCtD
Anastrozole—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.0017	CcSEcCtD
Anastrozole—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000246	0.00813	CbGpPWpGaD
Anastrozole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00169	CcSEcCtD
Anastrozole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00169	CcSEcCtD
Anastrozole—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00169	CcSEcCtD
Anastrozole—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00169	CcSEcCtD
Anastrozole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00168	CcSEcCtD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000244	0.00806	CbGpPWpGaD
Anastrozole—Infection—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00168	CcSEcCtD
Anastrozole—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00168	CcSEcCtD
Anastrozole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00166	CcSEcCtD
Anastrozole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00166	CcSEcCtD
Anastrozole—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00166	CcSEcCtD
Anastrozole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000241	0.00166	CcSEcCtD
Anastrozole—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00166	CcSEcCtD
Anastrozole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.00165	CcSEcCtD
Anastrozole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00165	CcSEcCtD
Anastrozole—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00024	0.00165	CcSEcCtD
Anastrozole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00164	CcSEcCtD
Anastrozole—Infection—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00164	CcSEcCtD
Anastrozole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000237	0.00163	CcSEcCtD
Anastrozole—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00782	CbGpPWpGaD
Anastrozole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00162	CcSEcCtD
Anastrozole—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000232	0.00765	CbGpPWpGaD
Anastrozole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00159	CcSEcCtD
Anastrozole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00159	CcSEcCtD
Anastrozole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00158	CcSEcCtD
Anastrozole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.00157	CcSEcCtD
Anastrozole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.00156	CcSEcCtD
Anastrozole—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00156	CcSEcCtD
Anastrozole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000224	0.00154	CcSEcCtD
Anastrozole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.00154	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00154	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00154	CcSEcCtD
Anastrozole—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000223	0.00736	CbGpPWpGaD
Anastrozole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00153	CcSEcCtD
Anastrozole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00153	CcSEcCtD
Anastrozole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00152	CcSEcCtD
Anastrozole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.00152	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00151	CcSEcCtD
Anastrozole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000219	0.0015	CcSEcCtD
Anastrozole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.0015	CcSEcCtD
Anastrozole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000218	0.0015	CcSEcCtD
Anastrozole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.0015	CcSEcCtD
Anastrozole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00149	CcSEcCtD
Anastrozole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00148	CcSEcCtD
Anastrozole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00148	CcSEcCtD
Anastrozole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00148	CcSEcCtD
Anastrozole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000215	0.00148	CcSEcCtD
Anastrozole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000214	0.00706	CbGpPWpGaD
Anastrozole—Injury—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00147	CcSEcCtD
Anastrozole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000213	0.00147	CcSEcCtD
Anastrozole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.00147	CcSEcCtD
Anastrozole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00146	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00146	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00146	CcSEcCtD
Anastrozole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00145	CcSEcCtD
Anastrozole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00145	CcSEcCtD
Anastrozole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00145	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00145	CcSEcCtD
Anastrozole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00144	CcSEcCtD
Anastrozole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00144	CcSEcCtD
Anastrozole—Pain—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00144	CcSEcCtD
Anastrozole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00144	CcSEcCtD
Anastrozole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00144	CcSEcCtD
Anastrozole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00144	CcSEcCtD
Anastrozole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00143	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00143	CcSEcCtD
Anastrozole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00142	CcSEcCtD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000207	0.00681	CbGpPWpGaD
Anastrozole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00142	CcSEcCtD
Anastrozole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00142	CcSEcCtD
Anastrozole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000205	0.00678	CbGpPWpGaD
Anastrozole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00141	CcSEcCtD
Anastrozole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.00141	CcSEcCtD
Anastrozole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00141	CcSEcCtD
Anastrozole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.0014	CcSEcCtD
Anastrozole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.0014	CcSEcCtD
Anastrozole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.0014	CcSEcCtD
Anastrozole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.0014	CcSEcCtD
Anastrozole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.0014	CcSEcCtD
Anastrozole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00139	CcSEcCtD
Anastrozole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00139	CcSEcCtD
Anastrozole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000202	0.00139	CcSEcCtD
Anastrozole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00138	CcSEcCtD
Anastrozole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.00138	CcSEcCtD
Anastrozole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00138	CcSEcCtD
Anastrozole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00138	CcSEcCtD
Anastrozole—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00138	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00138	CcSEcCtD
Anastrozole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00137	CcSEcCtD
Anastrozole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00136	CcSEcCtD
Anastrozole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00136	CcSEcCtD
Anastrozole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00135	CcSEcCtD
Anastrozole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00135	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000195	0.00643	CbGpPWpGaD
Anastrozole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00642	CbGpPWpGaD
Anastrozole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00134	CcSEcCtD
Anastrozole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00134	CcSEcCtD
Anastrozole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00133	CcSEcCtD
Anastrozole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000194	0.00133	CcSEcCtD
Anastrozole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00133	CcSEcCtD
Anastrozole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.00133	CcSEcCtD
Anastrozole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000193	0.00133	CcSEcCtD
Anastrozole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.00132	CcSEcCtD
Anastrozole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000191	0.00132	CcSEcCtD
Anastrozole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000191	0.00132	CcSEcCtD
Anastrozole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000191	0.00131	CcSEcCtD
Anastrozole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.00131	CcSEcCtD
Anastrozole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00131	CcSEcCtD
Anastrozole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00131	CcSEcCtD
Anastrozole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00131	CcSEcCtD
Anastrozole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.0013	CcSEcCtD
Anastrozole—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00129	CcSEcCtD
Anastrozole—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00129	CcSEcCtD
Anastrozole—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00128	CcSEcCtD
Anastrozole—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000184	0.00607	CbGpPWpGaD
Anastrozole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00127	CcSEcCtD
Anastrozole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00126	CcSEcCtD
Anastrozole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00126	CcSEcCtD
Anastrozole—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000182	0.00599	CbGpPWpGaD
Anastrozole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.00124	CcSEcCtD
Anastrozole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000181	0.00124	CcSEcCtD
Anastrozole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00018	0.00124	CcSEcCtD
Anastrozole—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00018	0.00592	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00018	0.00592	CbGpPWpGaD
Anastrozole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000179	0.00591	CbGpPWpGaD
Anastrozole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000177	0.00122	CcSEcCtD
Anastrozole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00121	CcSEcCtD
Anastrozole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00121	CcSEcCtD
Anastrozole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00119	CcSEcCtD
Anastrozole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00119	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00119	CcSEcCtD
Anastrozole—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00568	CbGpPWpGaD
Anastrozole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00119	CcSEcCtD
Anastrozole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00568	CbGpPWpGaD
Anastrozole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00117	CcSEcCtD
Anastrozole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00017	0.00117	CcSEcCtD
Anastrozole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00115	CcSEcCtD
Anastrozole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00115	CcSEcCtD
Anastrozole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00114	CcSEcCtD
Anastrozole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00114	CcSEcCtD
Anastrozole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00113	CcSEcCtD
Anastrozole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00113	CcSEcCtD
Anastrozole—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.00112	CcSEcCtD
Anastrozole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00112	CcSEcCtD
Anastrozole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00112	CcSEcCtD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00532	CbGpPWpGaD
Anastrozole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00109	CcSEcCtD
Anastrozole—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000159	0.00523	CbGpPWpGaD
Anastrozole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00109	CcSEcCtD
Anastrozole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00107	CcSEcCtD
Anastrozole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00107	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.00512	CbGpPWpGaD
Anastrozole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00106	CcSEcCtD
Anastrozole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00106	CcSEcCtD
Anastrozole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00106	CcSEcCtD
Anastrozole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00106	CcSEcCtD
Anastrozole—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00106	CcSEcCtD
Anastrozole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00106	CcSEcCtD
Anastrozole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00106	CcSEcCtD
Anastrozole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00106	CcSEcCtD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.00505	CbGpPWpGaD
Anastrozole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00105	CcSEcCtD
Anastrozole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00105	CcSEcCtD
Anastrozole—Rash—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00104	CcSEcCtD
Anastrozole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00104	CcSEcCtD
Anastrozole—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.00498	CbGpPWpGaD
Anastrozole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00104	CcSEcCtD
Anastrozole—Depression—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00104	CcSEcCtD
Anastrozole—Headache—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00104	CcSEcCtD
Anastrozole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00103	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00491	CbGpPWpGaD
Anastrozole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00102	CcSEcCtD
Anastrozole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Anastrozole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Anastrozole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00101	CcSEcCtD
Anastrozole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.00101	CcSEcCtD
Anastrozole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.001	CcSEcCtD
Anastrozole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.001	CcSEcCtD
Anastrozole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.001	CcSEcCtD
Anastrozole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000146	0.001	CcSEcCtD
Anastrozole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000998	CcSEcCtD
Anastrozole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000981	CcSEcCtD
Anastrozole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000966	CcSEcCtD
Anastrozole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000946	CcSEcCtD
Anastrozole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000942	CcSEcCtD
Anastrozole—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000939	CcSEcCtD
Anastrozole—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000934	CcSEcCtD
Anastrozole—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000136	0.00447	CbGpPWpGaD
Anastrozole—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000914	CcSEcCtD
Anastrozole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000914	CcSEcCtD
Anastrozole—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.0043	CbGpPWpGaD
Anastrozole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000883	CcSEcCtD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000128	0.00421	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00417	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000126	0.00415	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00415	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000124	0.0041	CbGpPWpGaD
Anastrozole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000826	CcSEcCtD
Anastrozole—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000826	CcSEcCtD
Anastrozole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00082	CcSEcCtD
Anastrozole—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00393	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00393	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00393	CbGpPWpGaD
Anastrozole—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000813	CcSEcCtD
Anastrozole—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000117	0.00387	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000116	0.00383	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000116	0.00382	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000114	0.00376	CbGpPWpGaD
Anastrozole—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000781	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.00372	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00368	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00367	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00362	CbGpPWpGaD
Anastrozole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000755	CcSEcCtD
Anastrozole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000753	CcSEcCtD
Anastrozole—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000752	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000109	0.0036	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.00357	CbGpPWpGaD
Anastrozole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000743	CcSEcCtD
Anastrozole—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000733	CcSEcCtD
Anastrozole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000726	CcSEcCtD
Anastrozole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000105	0.00345	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00338	CbGpPWpGaD
Anastrozole—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000702	CcSEcCtD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00333	CbGpPWpGaD
Anastrozole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000692	CcSEcCtD
Anastrozole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000692	CcSEcCtD
Anastrozole—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00069	CcSEcCtD
Anastrozole—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.000684	CcSEcCtD
Anastrozole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9.78e-05	0.000673	CcSEcCtD
Anastrozole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000664	CcSEcCtD
Anastrozole—Oedema—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000664	CcSEcCtD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.63e-05	0.00318	CbGpPWpGaD
Anastrozole—Infection—Prednisone—chronic obstructive pulmonary disease	9.58e-05	0.000659	CcSEcCtD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.51e-05	0.00314	CbGpPWpGaD
Anastrozole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.33e-05	0.000642	CcSEcCtD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.2e-05	0.00303	CbGpPWpGaD
Anastrozole—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.000633	CcSEcCtD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.14e-05	0.00301	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	8.83e-05	0.00291	CbGpPWpGaD
Anastrozole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.79e-05	0.000605	CcSEcCtD
Anastrozole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.78e-05	0.000604	CcSEcCtD
Anastrozole—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.0006	CcSEcCtD
Anastrozole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000596	CcSEcCtD
Anastrozole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000584	CcSEcCtD
Anastrozole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.000577	CcSEcCtD
Anastrozole—Rash—Prednisolone—chronic obstructive pulmonary disease	8.37e-05	0.000576	CcSEcCtD
Anastrozole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.36e-05	0.000575	CcSEcCtD
Anastrozole—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000572	CcSEcCtD
Anastrozole—Headache—Prednisolone—chronic obstructive pulmonary disease	8.32e-05	0.000572	CcSEcCtD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.3e-05	0.00274	CbGpPWpGaD
Anastrozole—Constipation—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000568	CcSEcCtD
Anastrozole—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	8.14e-05	0.00268	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.04e-05	0.00265	CbGpPWpGaD
Anastrozole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.95e-05	0.000547	CcSEcCtD
Anastrozole—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.95e-05	0.00262	CbGpPWpGaD
Anastrozole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000543	CcSEcCtD
Anastrozole—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.89e-05	0.000543	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.81e-05	0.00258	CbGpPWpGaD
Anastrozole—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000527	CcSEcCtD
Anastrozole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.63e-05	0.000525	CcSEcCtD
Anastrozole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.63e-05	0.000525	CcSEcCtD
Anastrozole—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	7.48e-05	0.00247	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.44e-05	0.00245	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.34e-05	0.00242	CbGpPWpGaD
Anastrozole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.11e-05	0.000489	CcSEcCtD
Anastrozole—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.000476	CcSEcCtD
Anastrozole—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.87e-05	0.00227	CbGpPWpGaD
Anastrozole—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.82e-05	0.00047	CcSEcCtD
Anastrozole—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.79e-05	0.00224	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.68e-05	0.0022	CbGpPWpGaD
Anastrozole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000454	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.59e-05	0.00217	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.59e-05	0.00217	CbGpPWpGaD
Anastrozole—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000439	CcSEcCtD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.29e-05	0.00208	CbGpPWpGaD
Anastrozole—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.13e-05	0.000422	CcSEcCtD
Anastrozole—Rash—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000419	CcSEcCtD
Anastrozole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000418	CcSEcCtD
Anastrozole—Headache—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000416	CcSEcCtD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.03e-05	0.00199	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.85e-05	0.00193	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.8e-05	0.00191	CbGpPWpGaD
Anastrozole—Nausea—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000394	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.7e-05	0.00188	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	5.69e-05	0.00188	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.65e-05	0.00186	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.58e-05	0.00184	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.57e-05	0.00184	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.5e-05	0.00181	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.3e-05	0.00175	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.29e-05	0.00174	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.24e-05	0.00173	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	5.13e-05	0.00169	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.12e-05	0.00169	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.12e-05	0.00169	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.05e-05	0.00167	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.02e-05	0.00166	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.02e-05	0.00166	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.85e-05	0.0016	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.83e-05	0.00159	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.79e-05	0.00158	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.78e-05	0.00158	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.78e-05	0.00158	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.76e-05	0.00157	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.7e-05	0.00155	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.41e-05	0.00145	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.38e-05	0.00144	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.35e-05	0.00143	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.32e-05	0.00142	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.31e-05	0.00142	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.00139	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.15e-05	0.00137	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.09e-05	0.00135	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.91e-05	0.00129	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.68e-05	0.00121	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.62e-05	0.0012	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.38e-05	0.00111	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.34e-05	0.0011	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.33e-05	0.0011	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.2e-05	0.00106	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.16e-05	0.00104	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.11e-05	0.00102	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.07e-05	0.00101	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.86e-05	0.000945	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.8e-05	0.000924	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.78e-05	0.000918	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.59e-05	0.000853	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.58e-05	0.000852	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.58e-05	0.00085	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.57e-05	0.000846	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.52e-05	0.00083	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.38e-05	0.000785	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.34e-05	0.000772	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.21e-05	0.000729	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.15e-05	0.00071	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.15e-05	0.000709	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.12e-05	0.000701	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2e-05	0.000659	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.98e-05	0.000653	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.88e-05	0.000619	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	0.000615	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.71e-05	0.000563	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.66e-05	0.000547	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000525	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.54e-05	0.000509	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.37e-05	0.000453	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.36e-05	0.000448	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000421	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.27e-05	0.000418	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000409	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.22e-05	0.000402	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.17e-05	0.000388	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.16e-05	0.000383	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.000377	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.08e-05	0.000357	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.00035	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.53e-06	0.000314	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.4e-06	0.00031	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.07e-06	0.000299	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.96e-06	0.000296	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.76e-06	0.000289	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.3e-06	0.000274	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.18e-06	0.00027	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.14e-06	0.000269	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.03e-06	0.000265	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.54e-06	0.000249	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.48e-06	0.000247	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.09e-06	0.000234	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.29e-06	0.000207	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.2e-06	0.000204	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.78e-06	0.00019	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.64e-06	0.000186	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.48e-06	0.000181	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.4e-06	0.000178	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.82e-06	0.000159	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.61e-06	0.000152	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.72e-06	0.000123	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.56e-06	0.000117	CbGpPWpGaD
